|
Normah Newsletter -
Issue No. 1 /2002
BACTERIA MENINGITIS
What is Meningococcal Disease?
Meningococcal disease is caused by the bacterium, Neisseria
meningitidis. The severity of the disease can range from asymtomatic
carrier state to an acute illness, either meningitis (infection of
the brain covering), pneumonia (infection of the lungs), to
meningococcemia (disseminated meningococcal infection), which can be
mild or serious. It is quite common for patients to develop a mild
upper respiratory infection before proceeding to an acute neisseria
infection (acute meningtis). Spread is by cough droplets or close
contacts. Symptoms include fever, chills, malaise, body aches,
arthralgia, joint effusion, headache and petechial rash. In the most
severe form of infection patient can develop low blood pressure and
shock, resulting in death.
What is meningitis?
Bacteria meningitis can be quite severe and may result in brain
damage, hearing loss, or learning disability. For bacterial
meningitis, it is important to know which type of bacteria is
causing the meningitis because antibiotics can prevent some types
from spreading and infecting other people as well as treating the
disease.
What are the signs and symptoms of meningitis?
High fever, headache, and stiff neck are common symptoms of
meningitis in anyone over the age of 2 years. These symptoms can
develop over several hours, or they may ake 1 to 2 days. Other
symptoms may include nausea, vomiting, discomfort looking into
bright lights, confusion, and sleepiness. In newborns and small
infants, the classic symptoms of fever, headache, and neck stiffness
may be absent or difficult to detect, and the infant may only appear
slow or inactive, or be irritable, have vomiting, or be feeding
poorly. As the disease progresses, patients of any age may have
seizures.
How is the meningitis diagnosed?
The diagnosis is usually made by blood and spinal fluid testing.
Early diagnosis and treatment are very important. If symptoms occur,
the patient should see a doctor immediately.
How can meningitis be treated?
Bacteria meningitis can be treated with a number of effective
antobiotic. It is important, however, that treatment be started
early in the course of the disease. Appropriate antibiotic treatment
should reduce the risk of dying from meningitis, although the risk
is higher among the elderly.
Is meningitis contagious?
Yes, some forms of bacterial meningitis are contagious. The bacteria
are spread through the exchange of respiratory and throat secretions
(i.e., coughing, kissing). Fortunately, none of the bacteria that
cause meningitis are as contagious as things like the common cold or
the flu, and they are not spread by casual contact or by simply
breathing the air where a person with meningitis has been.
However, sometimes the bacteria that cause meningitis have spread to
other people who have had close or prolonged contact with a patient
with meningitis caused by Neisseria meningitidis (also called
meningococcal meningitis) or Hib. People in the same household or
day-care center, or anyone with direct contact with a patient's oral
secretions would be considered at increased risk of acquiring the
infection. People who qualify as close contacts of a person with
meningitis caused by N. meningitidis should receive antibiotics to
prevent them from getting the disease.
Are there vaccines against meningococcal meningitis?
Yes, there are vaccines available for protection of the public in
the event of an outbreak and there are various antibiotics that are
used for close contacts of patients proven to have meningococcal
infections.
The quadrivalent A, C, Y and W-135 vaccine is the most commonly
used.
Dosage is a single dose of 0.5ml given under the skin. Vaccination
is effective in up to 85 - 95% of older children (4 - 5 years of
age) and adults. In those less than 4 years of age, vaccination may
elicit protection but the protective antibodies is less and last for
much shorter period of time.
Protective antibody may be achieved within 7 - 10 days. Levels of
antibodies against serogroup A & C decrease markedly during the
first three years. Common adverse reactions post vaccination are
pain, redness at injection site for 1 - 2 days, transient fever,
headache, malaise and chills.
Chemoprophylaxis antibiotic coverage for close contacts:
Adults: Rifampicin* 600mg 12 hourly x 2 days
or Ciprofloxacin 500mg stat
or Ofloxacin 400mg stat
Children:
> 1 year: Rifampicin 10mg/kg 12 hourly x 2 days
< 1 year: Rifampicin 5mg/kg 12 hourly x 2 days
Pregnant women: IM Ceftriaxone 250mg stat
*Rifampicin may cause red urine.
|